HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics AG (NBRV), sold 52,412 shares at $11.40 ($589K) on 2017-04-11, disclosed to the SEC on 2017-04-13.
Open-market sale of $589k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.40 | 8,597 | $98K | 16.6% |
| 2 | $11.40 | 8,597 | $98K | 16.6% |
| 3 | $11.22 | 13,250 | $149K | 25.2% |
| 4 | $11.13 | 10,984 | $122K | 20.7% |
| 5 | $11.13 | 10,984 | $122K | 20.7% |
| Total | $11.24 avg | 52,412 |
| $589K |
| 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |